Authors: VANDENBOSH F RUSSELL A KEYSTONE EC MORELAND LW STCLAIR E WEINBLATT M LIPSKY P BULPITT KJ KUCHARSKI K GRINT P WHERRY JC

Citation: F. Vandenbosh et al., RHUIL-4 IN SUBJECTS WITH ACTIVE RHEUMATOID-ARTHRITIS (RA) - A PHASE-1DOSE ESCALATING SAFETY STUDY, Arthritis and rheumatism, 41(9), 1998, pp. 144-144

Authors: MAINI RN PAULUS H BREEDVELD FC MORELAND LW STCLAIR EW RUSSELL AS CHARLES P DAVIES D GRINT P WHERRY JC FELDMANN M

Citation: Rn. Maini et al., RHUIL-10 IN SUBJECTS WITH ACTIVE RHEUMATOID-ARTHRITIS (RA) - A PHASE-I AND CYTOKINE RESPONSE STUDY, Arthritis and rheumatism, 40(9), 1997, pp. 1161-1161

Authors: ABRAHAM E WUNDERINK R SILVERMAN H PERL TM NASRAWAY S LEVY H BONE R WENZEL RP BALK R ALLRED R PENNINGTON JE WHERRY JC

Citation: E. Abraham et al., EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL, JAMA, the journal of the American Medical Association, 273(12), 1995, pp. 934-941

Authors: SARAVOLATZ LD WHERRY JC SPOONER C MARKOWITZ N ALLRED R REMICK D FOURNEL M PENNINGTON JE

Citation: Ld. Saravolatz et al., CLINICAL SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF MURINE MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA, The Journal of infectious diseases, 169(1), 1994, pp. 214-217

Authors: WHERRY JC PENNINGTON JE WENZEL RP

Citation: Jc. Wherry et al., TUMOR-NECROSIS-FACTOR AND THE THERAPEUTIC POTENTIAL OF ANTITUMOR NECROSIS FACTOR ANTIBODIES, Critical care medicine, 21(10), 1993, pp. 190000436-190000440